Self-styled “digital clinical research organisation” Clinipace Worldwide has boosted its regulatory and strategic development expertise by acquiring fellow US company Regulus Pharmaceutical Consulting for an undisclosed sum.
The acquisition expands Clinipace’s staff count by 20%, with new team members adding an average of 18 years’ experience in the life sciences industry, the CRO noted.
The Regulus team will remain in Boulder, Colorado with the same management structure and personnel. Regulus will now operate as the Regulatory Affairs, Strategic Development and Quality Assurance consultancy division of Clinipace Worldwide.
As well as significantly expanding Clinipace’s regulatory and strategic development capabilities, Regulus adds further weight to the CRO’s in-house regulatory publishing and medical writing groups.
Brenda Fielding, president of Regulus, becomes executive vice president of regulatory affairs for Clinipace Worldwide, reporting directly to Christopher Porter, the latter’s chief operating officer. Fielding will be responsible for directing all of Clinipace’s regulatory affairs and quality assurance consulting services from the Boulder office.
“Regulus’ expertise is a strategic fit for Clinipace Worldwide as they provide a unique resource of experience and skills to meet the requirements of our biopharmaceutical and medical device clients,” commented Jeff Williams, chief executive officer of Clinipace Worldwide.
Together the two companies “can ensure all relevant disciplines are involved in a clinical development project, from initial concept to regulatory strategy and submissions, quality systems implementation, clinical operations, through to the final delivery of the completed project”, added Fielding.
The Clinipace Worldwide name was adopted in November 2009 after Clinipace acquired fellow US CRO Worldwide Clinical Research, building on Clinipace’s core expertise in clinical research software and raising its global profile.
Clinipace Worldwide’s corporate headquarters are in Research Triangle Park, North Carolina. As well as the new Boulder, Colorado office, the company has domestic operations in Overland Park, Kansas and a South American presence in Sao Paulo (Brazil), Buenos Aires (Argentina) and Lima (Peru).